Functional crosstalk of nucleus accumbens CB1 and OX2 receptors in response to nicotine-induced place preference.
Animals
Conditioning, Operant
/ drug effects
Conditioning, Psychological
/ drug effects
Male
Nicotine
/ pharmacology
Nucleus Accumbens
/ drug effects
Orexin Receptor Antagonists
/ pharmacology
Orexin Receptors
/ drug effects
Piperidines
/ pharmacology
Pyrazoles
/ pharmacology
Rats, Wistar
Receptor, Cannabinoid, CB1
/ antagonists & inhibitors
Cannabinoid receptors
Condition place preference
Nicotine
Nucleus accumbens core
Orexin receptors
Journal
Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130
Informations de publication
Date de publication:
17 04 2019
17 04 2019
Historique:
received:
04
08
2018
revised:
17
12
2018
accepted:
15
01
2019
pubmed:
20
1
2019
medline:
11
9
2019
entrez:
20
1
2019
Statut:
ppublish
Résumé
In the present study, we have evaluated the existence of functional interaction between orexin-2 receptor (OX2R) and cannabinoid-1 receptor (CB1R) in the nucleus accumbens core (NAcc), in nicotine-induced conditioned place preference (CPP) of Wistar male rat. Nicotine (0.5 mg/kg; s.c.) in the course of conditioning, produced a significant place preference, without any effect on the locomotor activity. Intra-NAcc administration of ineffective and effective doses of TCS-OX2-29 (2 and 6 ng/rat), a selective OX2R antagonist and AM251 (10 and 50 ng/rat), a selective CB1R antagonist, showed a significant interaction between OX2R and CB1R in the acquisition of nicotine-induced CPP (p < 0.01), and the locomotor activity (p < 0.05). No significant interaction was observed between these two receptors in the expression of nicotine-induced CPP. Our findings provide insight into the possible interaction of OX2R and CB1R of the NAcc in nicotine addiction. We propose a potential interaction between cannabinoid and orexinergic systems within the NAcc, in producing the rewarding effects.
Identifiants
pubmed: 30659912
pii: S0304-3940(19)30039-4
doi: 10.1016/j.neulet.2019.01.027
pii:
doi:
Substances chimiques
Orexin Receptor Antagonists
0
Orexin Receptors
0
Piperidines
0
Pyrazoles
0
Receptor, Cannabinoid, CB1
0
AM 251
3I4FA44MAI
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-164Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.